Free Trial

Trading of Monogram Orthopaedics was halted at 07:28 AM EST due to "News pending".

Monogram Orthopaedics (MGRM) Stock Price, News & Analysis

Monogram Orthopaedics logo
$5.87 +2.58 (+78.42%)
Closing price 04:00 PM Eastern
Extended Trading
$5.73 -0.14 (-2.39%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Monogram Orthopaedics Stock (NASDAQ:MGRM)

Key Stats

Today's Range
$5.17
$6.02
50-Day Range
$2.41
$3.31
52-Week Range
$1.92
$6.02
Volume
14.31 million shs
Average Volume
450,809 shs
Market Capitalization
$209.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.40
Consensus Rating
Strong Buy

Company Overview

Monogram Orthopaedics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

MGRM MarketRank™: 

Monogram Orthopaedics scored higher than 23% of companies evaluated by MarketBeat, and ranked 849th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Monogram Orthopaedics has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Monogram Orthopaedics has received no research coverage in the past 90 days.

  • Read more about Monogram Orthopaedics' stock forecast and price target.
  • Earnings Growth

    Earnings for Monogram Orthopaedics are expected to grow in the coming year, from ($0.49) to ($0.46) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Monogram Orthopaedics is -13.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Monogram Orthopaedics is -13.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Monogram Orthopaedics has a P/B Ratio of 13.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Monogram Orthopaedics' valuation and earnings.
  • Percentage of Shares Shorted

    2.14% of the float of Monogram Orthopaedics has been sold short.
  • Short Interest Ratio / Days to Cover

    Monogram Orthopaedics has a short interest ratio ("days to cover") of 8.1.
  • Change versus previous month

    Short interest in Monogram Orthopaedics has recently increased by 6.36%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Monogram Orthopaedics does not currently pay a dividend.

  • Dividend Growth

    Monogram Orthopaedics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.14% of the float of Monogram Orthopaedics has been sold short.
  • Short Interest Ratio / Days to Cover

    Monogram Orthopaedics has a short interest ratio ("days to cover") of 8.1.
  • Change versus previous month

    Short interest in Monogram Orthopaedics has recently increased by 6.36%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Monogram Orthopaedics has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Monogram Orthopaedics this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for MGRM on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Monogram Orthopaedics to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Monogram Orthopaedics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    28.10% of the stock of Monogram Orthopaedics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.45% of the stock of Monogram Orthopaedics is held by institutions.

  • Read more about Monogram Orthopaedics' insider trading history.
Receive MGRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Monogram Orthopaedics and its competitors with MarketBeat's FREE daily newsletter.

MGRM Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Zimmer Biomet to buy Monogram for $177M in cash
See More Headlines

MGRM Stock Analysis - Frequently Asked Questions

Monogram Orthopaedics' stock was trading at $2.37 at the start of the year. Since then, MGRM stock has increased by 147.7% and is now trading at $5.87.

Monogram Orthopaedics Inc. (NASDAQ:MGRM) released its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02.
Read the conference call transcript
.

Monogram Orthopaedics (MGRM) raised $17 million in an initial public offering (IPO) on Thursday, May 18th 2023. The company issued 2,374,641 shares at a price of $7.25 per share.

Shares of MGRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Monogram Orthopaedics investors own include Mullen Automotive (MULN), Faraday Future Intelligent Electric (FFIE), Plug Power (PLUG), AMC Entertainment (AMC), CXApp (CXAI), Draganfly (DPRO) and

Company Calendar

Last Earnings
5/14/2025
Today
7/14/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MGRM
CIK
1769759
Fax
N/A
Employees
28
Year Founded
N/A

Price Target and Rating

High Price Target
$5.40
Low Price Target
$5.40
Potential Upside/Downside
-5.3%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.33 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-115.71%
Return on Assets
-92.75%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.00
Quick Ratio
7.00

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.42 per share
Price / Book
13.57

Miscellaneous

Outstanding Shares
35,688,000
Free Float
25,660,000
Market Cap
$203.42 million
Optionable
Not Optionable
Beta
0.59
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:MGRM) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners